Alzheimer's disease (AD) is a neurodegenerative disease of the brain characterized by dementia, cognitive impairment and memory loss. Formation and accumulation of aggregates of &-amyloid (AB) peptides in the brain are critical factors contributing to the development and progression of AD. Currently, early appraisal of clinical symptoms for diagnosis of AD is often difficult and unreliable. Therefore, there is an urgent need for in vivo imaging agents, which can specifically demonstrate the location and density of amyloid plaques in the brain. The objective of this project is to develop potential 1-123 labeled diagnostic imaging agents specific for detection of AB plaques. Recent advances in developing tracers for binding A13 plaques suggest that there are specific and saturable binding sites on the aggregates of At3 that can be selectively labeled and imaged in vivo. The proposed agents are derivatives of stilbenes containing a p-MezN-, -SH, -SMe, -0Me or -OH group on one of the benzene rings, while radioactive iodine can be attached to the other benzene ring without affecting the binding affinity. They are simple, relatively small, neutral and lipophilic. On the basis of their exquisitely high binding affinity to At3140 aggregates (Ki at the range of 0.1-40 nM), they are suitable candidates as A&-plaque-selective imaging agents. They also showed ability to penetrate the intact blood-brain barrier, an essential pre-requisite for a useful plaque-imaging agent. The proposed synthesis and methodology provide a framework to test the hypothesis that small probes can be used to detect At3 plaques in vivo. The proposed compounds are innovative and carefully crafted to meet the stringent requirements for t3-amyloid imaging agents. Together with the compelling preliminary data presented in this project we believe that At3 plaque-selective imaging agents can be successfully developed. The At3-plaque-specific imaging agents will be useful for early detection or monitoring the progression and effectiveness of treatment of AD.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-SRB (06))
Program Officer
Buckholtz, Neil
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Schools of Medicine
United States
Zip Code
Song, Pu-Jiao; Barc, CĂ©line; Arlicot, Nicolas et al. (2010) Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes. Mol Imaging Biol 12:576-82
Song, Pu-Jiao; Bernard, Serge; Sarradin, Pierre et al. (2008) IMPY, a potential beta-amyloid imaging probe for detection of prion deposits in scrapie-infected mice. Nucl Med Biol 35:197-201
Stephenson, Karin A; Chandra, Rajesh; Zhuang, Zhi-Ping et al. (2007) Fluoro-pegylated (FPEG) imaging agents targeting Abeta aggregates. Bioconjug Chem 18:238-46
Qu, Wenchao; Kung, Mei-Ping; Hou, Catherine et al. (2007) Radioiodinated aza-diphenylacetylenes as potential SPECT imaging agents for beta-amyloid plaque detection. Bioorg Med Chem Lett 17:3581-4
Qu, Wenchao; Kung, Mei-Ping; Hou, Catherine et al. (2007) Novel styrylpyridines as probes for SPECT imaging of amyloid plaques. J Med Chem 50:2157-65
Qu, Wenchao; Kung, Mei-Ping; Hou, Catherine et al. (2007) Quick assembly of 1,4-diphenyltriazoles as probes targeting beta-amyloid aggregates in Alzheimer's disease. J Med Chem 50:3380-7
Zhang, Wei; Kung, Mei-Ping; Oya, Shunichi et al. (2007) 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging. Nucl Med Biol 34:89-97
Newberg, Andrew B; Wintering, Nancy A; Plossl, Karl et al. (2006) Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. J Nucl Med 47:748-54
Chandra, Rajesh; Kung, Mei-Ping; Kung, Hank F (2006) Design, synthesis, and structure-activity relationship of novel thiophene derivatives for beta-amyloid plaque imaging. Bioorg Med Chem Lett 16:1350-2
Zhuang, Zhi-Ping; Kung, Mei-Ping; Kung, Hank F (2006) Synthesis of biphenyltrienes as probes for beta-amyloid plaques. J Med Chem 49:2841-4

Showing the most recent 10 out of 12 publications